DK1989323T3 - Diagnostiske fremgangsmåder der involverer bestemmelse af genkopiantal og SNP'er i Fc RII/Fc-RIII-genklynger og prøver til anvendelse i sådanne fremgangsmåder til at detektere modtagelighed for og behandlingseffektivitet i autoimmune sygdomme - Google Patents

Diagnostiske fremgangsmåder der involverer bestemmelse af genkopiantal og SNP'er i Fc RII/Fc-RIII-genklynger og prøver til anvendelse i sådanne fremgangsmåder til at detektere modtagelighed for og behandlingseffektivitet i autoimmune sygdomme

Info

Publication number
DK1989323T3
DK1989323T3 DK06835684.9T DK06835684T DK1989323T3 DK 1989323 T3 DK1989323 T3 DK 1989323T3 DK 06835684 T DK06835684 T DK 06835684T DK 1989323 T3 DK1989323 T3 DK 1989323T3
Authority
DK
Denmark
Prior art keywords
gene
amount
subject
rii
snps
Prior art date
Application number
DK06835684.9T
Other languages
English (en)
Inventor
Dirk Roos
Taco Willem Kuijpers
Original Assignee
Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanquin Bloedvoorziening filed Critical Sanquin Bloedvoorziening
Application granted granted Critical
Publication of DK1989323T3 publication Critical patent/DK1989323T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK06835684.9T 2005-12-22 2006-12-22 Diagnostiske fremgangsmåder der involverer bestemmelse af genkopiantal og SNP'er i Fc RII/Fc-RIII-genklynger og prøver til anvendelse i sådanne fremgangsmåder til at detektere modtagelighed for og behandlingseffektivitet i autoimmune sygdomme DK1989323T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05077984A EP1801234A1 (en) 2005-12-22 2005-12-22 Diagnostic methods involving determining gene copy numbers and use thereof
PCT/NL2006/000662 WO2007073179A2 (en) 2005-12-22 2006-12-22 DIAGNOSTIC METHODS INVOLVING DETERMINING GENE COPY NUMBERS AND SNPs IN THE FcϜRII/FcϜRIII GENE CLUSTER, AND PROBES FOR USE IN SUCH METHODS TO DETECT SUSCEPTIBILITY TO AND TREATMENT EFFICACY IN AUTOIMMUNE DISEASES

Publications (1)

Publication Number Publication Date
DK1989323T3 true DK1989323T3 (da) 2011-09-26

Family

ID=35953866

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06835684.9T DK1989323T3 (da) 2005-12-22 2006-12-22 Diagnostiske fremgangsmåder der involverer bestemmelse af genkopiantal og SNP'er i Fc RII/Fc-RIII-genklynger og prøver til anvendelse i sådanne fremgangsmåder til at detektere modtagelighed for og behandlingseffektivitet i autoimmune sygdomme

Country Status (10)

Country Link
US (2) US7994300B2 (da)
EP (2) EP1801234A1 (da)
AT (1) ATE515580T1 (da)
AU (1) AU2006327982A1 (da)
CA (1) CA2634692A1 (da)
DK (1) DK1989323T3 (da)
ES (1) ES2369415T3 (da)
PL (1) PL1989323T3 (da)
PT (1) PT1989323E (da)
WO (1) WO2007073179A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101192008B1 (ko) * 2007-10-09 2012-11-02 아크레이 가부시키가이샤 면역 관련 유전자의 다형의 검출용 프로브 및 그 용도
EP2055790A1 (en) * 2007-10-30 2009-05-06 Leibniz-Institut für Altersforschung - Fritz-Lipmann-Institut e.V. Calibration molecule and method for determining the number of copies of genes/target loci in a genome using said calibration molecule
US20120030144A1 (en) * 2007-11-08 2012-02-02 Pikamab, Inc. Methods for doing business using biomarkers
US20100330568A1 (en) * 2008-01-09 2010-12-30 Stefan Meuer Assay and method for the assessment of responders and non-responders to nk cell modulation by immunoglobulin therapy
WO2010080994A2 (en) * 2009-01-08 2010-07-15 The Uab Research Foundation Process for regulating immune response
JP2013518590A (ja) * 2010-02-02 2013-05-23 アボツト・バイオテクノロジー・リミテツド ＴＮＦ−α阻害剤を用いる処置に対する応答性を予測するための方法および組成物
WO2013075000A1 (en) * 2011-11-16 2013-05-23 University Of North Dakota Clustering copy-number values for segments of genomic data

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830652A (en) * 1994-08-30 1998-11-03 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Method for determining predisposition to severe forms of autoimmune disease by determining Fcy receptor allelic patterns
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US20030228617A1 (en) * 2002-05-16 2003-12-11 Vanderbilt University Method for predicting autoimmune diseases
US7425620B2 (en) * 2002-08-14 2008-09-16 Scott Koenig FcγRIIB-specific antibodies and methods of use thereof
US20080248465A1 (en) 2004-04-26 2008-10-09 Uab Research Foundation Polymorphisms in the Fcgr2b Promoter and Uses Thereof

Also Published As

Publication number Publication date
PT1989323E (pt) 2011-09-29
US8765372B2 (en) 2014-07-01
EP1989323B1 (en) 2011-07-06
CA2634692A1 (en) 2007-06-28
US20110189672A1 (en) 2011-08-04
ATE515580T1 (de) 2011-07-15
EP1989323A2 (en) 2008-11-12
WO2007073179A3 (en) 2008-01-17
AU2006327982A1 (en) 2007-06-28
PL1989323T3 (pl) 2011-12-30
AU2006327982A8 (en) 2008-07-24
ES2369415T3 (es) 2011-11-30
US7994300B2 (en) 2011-08-09
EP1801234A1 (en) 2007-06-27
US20090263795A1 (en) 2009-10-22
WO2007073179A2 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
Singh et al. Lymphoma driver mutations in the pathogenic evolution of an iconic human autoantibody
Kirsch et al. T-cell receptor profiling in cancer
DK1989323T3 (da) Diagnostiske fremgangsmåder der involverer bestemmelse af genkopiantal og SNP'er i Fc RII/Fc-RIII-genklynger og prøver til anvendelse i sådanne fremgangsmåder til at detektere modtagelighed for og behandlingseffektivitet i autoimmune sygdomme
ES2549184T3 (es) Método para evaluar y comparar inmunorepertorios
US20080166704A1 (en) Method for Quantitative Evaluation of a Rearrangement or a Targeted Genetic Recombination of an Individual and Uses Thereof
Li et al. Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses
KR102404285B1 (ko) 생물학적 샘플에서 개선된 성능을 갖는 igfbp7에 대한 분석
JP7054990B2 (ja) 炎症性腸疾患の診断及び治療のための方法
JP2015535820A5 (da)
CN102203609B (zh) 用于输血相关急性肺损伤(trali)的筛选方法
Kawa The immunobiology of immunoglobulin G4 and complement activation pathways in IgG4-related disease
CN112469434A (zh) 抗pla2-gib抗体及其用途
JP2021532792A (ja) Ｔｒｂｃ使用の分子的評価
SG187787A1 (en) Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies
CN110241204A (zh) Sox11作为精神分裂症诊断标记物的应用
Rahman et al. Failed up-regulation of the inhibitory IgG Fc receptor FcγRIIB on germinal center B cells in autoimmune-prone mice is not associated with deletion polymorphisms in the promoter region of the FcγRIIB gene
Yu et al. Outliers in RhD membrane integration are explained by variant RH haplotypes
JP2008500832A (ja) Ｆｃｇｒ３ａゲボタイプ（ｇｅｂｏｔｙｐｅ）および非枯渇性抗体に対する処置応答を評価するための方法
US20140213470A1 (en) Methods for use with baff antagonists
van der Rijst et al. Development of a recombinant anti‐Vel immunoglobulin M to identify Vel‐negative donors
CA2440960A1 (en) An early pre-symptomatic prion diagnostic blood test for encephalopathies
WO2022125448A1 (en) Systems and methods for producing disease-associated protein compositions
Yang et al. Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors
Yepes-Pérez et al. Molecular characterisation of parvorder Platyrrhini IgG sub-classes
US20110268753A1 (en) Process for regulating immune response